The FDA Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is excited to announce its upcoming virtual Advanced Manufacturing and Analytical Technologies (AMAT) for Regenerative Medicine Therapies (RMT) Workshop.

This workshop provides an opportunity for FDA review staff and cell and gene therapy stakeholders to obtain specialized knowledge from experts in the field of advanced manufacturing and analytical technologies (AMAT) for regenerative medicine therapies (RMT), discuss innovative technologies and alternative testing methods, and share experiences, challenges, and best practices critical for chemistry, manufacturing, and controls (CMC) of cellular and gene therapies and tissue engineered medical products. Individuals interested in attending this virtual workshop can register using the link provided below.

For more information, please visit the FDA website & Twitter.